- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jaime Davidson: The System Is Disruptive to Patients With Diabetes
Changes with health plans can be disruptive to patients with diabetes who face changes in supplies and medications that make it difficult to manage their disease, said Jaime A. Davidson, MD, FACP, MACE, professor of medicine, Touchstone Diabetes Center, The University of Texas Southwestern Medical Center.
Changes with health plans can be disruptive to patients with diabetes who face changes in supplies and medications that make it difficult to manage their disease, said Jaime A. Davidson, MD, FACP, MACE, professor of medicine, Touchstone Diabetes Center, The University of Texas Southwestern Medical Center.
Transcript
What challenges have your Medicare patients had in ordering diabetes supplies and has it affected their health?
Actually, it’s disruptive. I call the system disruptive. Because every year there are changes. We have an article actually that shows for supplies, especially for glucose sticks and meters, they decided to have a big change and when the patients receive the new meters or the new strips they didn’t know how to use them, they didn’t trust them, they didn’t use them, and actually that was very disruptive and people got out of control.
And the same is true for medications. Every year they change plans. It’s not just Medicare, it’s plans that we need to check on a yearly basis because this plan looks better. And then if one of the patients is taking, for example, one type of insulin, the new plan may not have it. And then they will exchange from a different insulin. And then, there’s a lot of confusion.
So, I call that part of the system disruptive. Economically, they think they save money, but at the end it costs us all more money, because the patients don’t do as well.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
